Apelin receptor (APJ) antagonist (IC50
values are 0.70 and 1.75 μ
M in a cAMP assay and β
-arrestin assay, respectively). Displays >37-fold selectivity over the closely related angiotensin II type 1 (AT1
) receptor. Exhibits no toxicity towards human hepatocytes at concentrations >50 μ
Soluble to 10 mM in DMSO
Store at +4°C
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Discovery of 4-oxo-6-((pyrimidin-2-ylthio)methyl)-4H-pyran-3-yl 4-nitrobenzoate (ML221) as a functional antagonist of the apelin (APJ) receptor.
Maloney et al.